Interleukin-17 Edges TNF Inhibitor in Psoriatic Arthritis Interleukin-17 Edges TNF Inhibitor in Psoriatic Arthritis

Early outcomes for the combined end point of skin clearance and disease activity in a comparison of biologics can give physicians confidence in the IL-17 inhibitor, SPIRIT-H2H investigators say.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news